Related Experiment Video
Updated: Jul 22, 2025

Performing and Processing FNA of Anterior Fat Pad for Amyloid
Published on: October 30, 2010
Chest pain in cardiac amyloidosis: occurrence, causes and prognostic significance
Laura De Michieli1, Monica De Gaspari2, Giulio Sinigiani1
1Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padua, Italy.
Insights
Chest pain is common in cardiac amyloidosis (CA), indicating advanced disease and predicting heart failure hospitalization. Etiologies differ by CA type, with obstructive coronary artery disease (CAD) in ATTR-CA and amyloid involvement in AL-CA.
Area of Science:
- Cardiology
- Cardiovascular Diseases
- Amyloidosis
Background:
- Chest pain is a known symptom in cardiac amyloidosis (CA).
- Systematic investigation of chest pain frequency, causes, and significance in CA is lacking.
Purpose of the Study:
- To investigate the frequency, etiologies, and clinical significance of chest pain in patients with cardiac amyloidosis.
- To differentiate the causes of chest pain between transthyretin amyloidosis (ATTR-CA) and light chain amyloidosis (AL-CA).
Main Methods:
- Analysis of clinical, echocardiographic, laboratory, coronary artery imaging, and endomyocardial biopsy (EMB) data from 174 CA patients (104 ATTR-CA, 70 AL-CA).
- Comparison of characteristics between CA patients with and without chest pain.
- Assessment of chest pain as a predictor of heart failure hospitalization.
Main Results:
- Chest pain was reported in 38% of CA patients.
- Patients with chest pain had higher rates of coronary artery disease (CAD) history, heart failure (HF) symptoms, and elevated cardiac biomarkers (hs-cTnI, BNP).
- Obstructive CAD was more frequent in ATTR-CA patients with chest pain (53% vs 0% in AL-CA), while vascular/perivascular amyloid deposition was more common in AL-CA patients (80% vs 20% in ATTR-CA).
- Chest pain predicted future HF hospitalization during follow-up.
Conclusions:
- Chest pain is a common symptom in CA, reflecting advanced cardiac impairment.
- Chest pain in CA predicts future heart failure hospitalizations.
- The underlying causes of chest pain in CA differ between ATTR-CA and AL-CA subtypes.
Background:
Chest pain is experienced by patients with cardiac amyloidosis (CA), but a systematic investigation of its frequency, underlying etiologies and clinical significance is lacking.
Methods:
Clinical, echocardiographic, laboratory characteristics, available coronary arteries imaging and endomyocardial biopsy (EMB) findings of 174 patients with CA (n = 104 with transthyretin, ATTR; n = 70 with light chains, AL) were analyzed.
Results:
Chest pain was reported in 66 (38%) CA patients. Compared to those without, patients with chest pain had more frequently a history of coronary artery disease (CAD) (27% vs 15%, p = 0.048) and heart failure (HF) symptoms (62% vs 43%, p = 0.015), higher high sensitivity troponin I (hs-cTnI, 101 vs 65 ng/L, p = 0.032) and higher brain natriuretic peptide (597 vs 407 ng/L, p = 0.024). Among CA patients with chest pain undergoing coronary arteries imaging (n = 37), obstructive CAD was detected in 14 (38%), 13 of whom with ATTR-CA. Of these 37 patients, EMB was available in 10 and vascular/perivascular amyloid deposition was detected in 4/5 (80%) of AL-CA patients and 1/5 ATTR-CA. Among patients with suspected acute coronary syndrome (n = 22), obstructive CAD was detected in 9/17 (53%) ATTR-CA and 0/5 AL-CA; hs-cTnI levels were similar between those with and without obstructive CAD. During a follow-up of 17 (8-34) months, chest pain was a significant predictor of HF hospitalization (HR1.86, 95% CI 1.02-3.39, p = 0.042), even after adjustment for CA subtype and CAD.
Conclusion:
Chest pain is a common symptom in patients with CA, reflects a more advanced cardiac impairment and predicts future HF hospitalization. The etiology of chest pain seems to differ, with obstructive CAD more frequent in ATTR-CA whilst amyloid vascular/perivascular involvement more common in AL-CA.
Related Concept Videos
Angina III: Clinical Manifestations and Assessment
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Pericarditis II: Clinical Features and Diagnostic Tests
Coronary Artery Disease III: Clinical Manifestations
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome III: Diagnostic Studies

